Active Biotech AB Release: New Information Regarding RhuDex(R)
LUND, SWEDEN--(Marketwire - October 17, 2008) - Lund, Sweden, October 17, 2008 - Active Biotech AB's (NASDAQ OMX Nordic: ACTI) collaboration partner MediGene AG (Frankfurt, Prime Standard: MDG) today announce information regarding the candidate drug RhuDex® for the treatment of rheumatoid arthritis.